Oppenheimer & Co’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-244
| Closed | -$4K | – | 1540 |
|
2022
Q1 | $4K | Buy |
+244
| New | +$4K | ﹤0.01% | 1463 |
|
2021
Q4 | – | Sell |
-383
| Closed | -$14K | – | 1574 |
|
2021
Q3 | $14K | Sell |
383
-382
| -50% | -$14K | ﹤0.01% | 1482 |
|
2021
Q2 | $46K | Sell |
765
-20
| -3% | -$1.2K | ﹤0.01% | 1489 |
|
2021
Q1 | $53K | Sell |
785
-500
| -39% | -$33.8K | ﹤0.01% | 1418 |
|
2020
Q4 | $77K | Buy |
1,285
+58
| +5% | +$3.48K | ﹤0.01% | 1317 |
|
2020
Q3 | $97K | Buy |
1,227
+248
| +25% | +$19.6K | ﹤0.01% | 1232 |
|
2020
Q2 | $61K | Buy |
979
+122
| +14% | +$7.6K | ﹤0.01% | 1229 |
|
2020
Q1 | $46K | Sell |
857
-115
| -12% | -$6.17K | ﹤0.01% | 1159 |
|
2019
Q4 | $118K | Sell |
972
-126
| -11% | -$15.3K | ﹤0.01% | 1235 |
|
2019
Q3 | $200K | Sell |
1,098
-873
| -44% | -$159K | 0.01% | 1145 |
|
2019
Q2 | $257K | Buy |
1,971
+1,110
| +129% | +$145K | 0.01% | 1070 |
|
2019
Q1 | $210K | Sell |
861
-407
| -32% | -$99.3K | 0.01% | 1200 |
|
2018
Q4 | $242K | Sell |
1,268
-27
| -2% | -$5.15K | 0.01% | 1034 |
|
2018
Q3 | $426K | Buy |
1,295
+118
| +10% | +$38.8K | 0.01% | 922 |
|
2018
Q2 | $366K | Sell |
1,177
-206
| -15% | -$64.1K | 0.01% | 987 |
|
2018
Q1 | $337K | Sell |
1,383
-152
| -10% | -$37K | 0.01% | 1002 |
|
2017
Q4 | $463K | Buy |
1,535
+49
| +3% | +$14.8K | 0.01% | 889 |
|
2017
Q3 | $393K | Buy |
1,486
+52
| +4% | +$13.8K | 0.01% | 938 |
|
2017
Q2 | $378K | Buy |
1,434
+605
| +73% | +$159K | 0.01% | 934 |
|
2017
Q1 | $298K | Buy |
829
+403
| +95% | +$145K | 0.01% | 1002 |
|
2016
Q4 | $123K | Buy |
+426
| New | +$123K | ﹤0.01% | 1219 |
|